The effects of pulmonary rehabilitation in the National Emphysema Treatment Trial

Andrew L. Ries, Barry J. Make, Shing M. Lee, Mark J. Krasna, Matthew N. Bartels, Rebecca Crouch, Alfred P. Fishman

Research output: Contribution to journalArticle

114 Citations (Scopus)

Abstract

Study objectives: Pulmonary rehabilitation is an established treatment in patients with chronic lung disease but is not widely utilized. Most trials have been conducted in single centers. The National Emphysema Treatment Trial (NETT) provided an opportunity to evaluate pulmonary rehabilitation in a large cohort of patients who were treated in centers throughout the United States. Design: Prospective observational study of cohort prior to randomization in a multicenter clinical trial. Setting: University-based clinical centers and community-based satellite pulmonary rehabilitation programs. Patients and intervention: A total of 1,218 patients with severe emphysema underwent pulmonary rehabilitation before and after randomization to lung volume reduction surgery (LVRS) or continued medical management. Rehabilitation was conducted at 17 NETT centers supplemented by 539 satellite centers. Measurements and results: Lung function, exercise tolerance, dyspnea, and quality of life were evaluated at regular intervals. Significant (p < 0.001) improvements were observed consistently in exercise (cycle ergometry, 3.1 W; 6-min walk test distance, 76 feet), dyspnea (University of California, San Diego Shortness of Breath Questionnaire score, -3.2; Borg breathlessness score: breathing cycle, -0.8; 6-min walk, -0.5) and quality of life (St. George Respiratory Questionnaire score, -3.5; Quality of Well-Being Scale score, +0.035; Medical Outcomes Study 36-item short form score: physical health summary, +1.3; mental health summary, + 2.0). Patients who had not undergone prior rehabilitation improved more than those who had. In multivariate models, only prior rehabilitation status predicted changes after rehabilitation. In 20% of patients, exercise level changed sufficiently after rehabilitation to alter the NETT subgroup predictive of outcome. Overall, changes after rehabilitation did not predict differential mortality or improvement in exercise (primary outcomes) by treatment group. Conclusions: The NETT experience demonstrates the effectiveness of pulmonary rehabilitation in patients with severe emphysema who were treated in a national cross-section of programs. Pulmonary rehabilitation plays an important role in preparing and selecting patients for surgical interventions such as LVRS.

Original languageEnglish (US)
Pages (from-to)3799-3809
Number of pages11
JournalChest
Volume128
Issue number6
DOIs
StatePublished - Dec 2005
Externally publishedYes

Fingerprint

Emphysema
Rehabilitation
Lung
Dyspnea
Therapeutics
Pneumonectomy
Exercise
Random Allocation
Quality of Life
Community Health Centers
Ergometry
Pulmonary Emphysema
Exercise Tolerance
Lung Diseases
Multicenter Studies
Observational Studies
Mental Health
Respiration
Chronic Disease
Outcome Assessment (Health Care)

Keywords

  • COPD
  • Pulmonary exercise
  • Pulmonary rehabilitation

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Ries, A. L., Make, B. J., Lee, S. M., Krasna, M. J., Bartels, M. N., Crouch, R., & Fishman, A. P. (2005). The effects of pulmonary rehabilitation in the National Emphysema Treatment Trial. Chest, 128(6), 3799-3809. https://doi.org/10.1378/chest.128.6.3799

The effects of pulmonary rehabilitation in the National Emphysema Treatment Trial. / Ries, Andrew L.; Make, Barry J.; Lee, Shing M.; Krasna, Mark J.; Bartels, Matthew N.; Crouch, Rebecca; Fishman, Alfred P.

In: Chest, Vol. 128, No. 6, 12.2005, p. 3799-3809.

Research output: Contribution to journalArticle

Ries, AL, Make, BJ, Lee, SM, Krasna, MJ, Bartels, MN, Crouch, R & Fishman, AP 2005, 'The effects of pulmonary rehabilitation in the National Emphysema Treatment Trial', Chest, vol. 128, no. 6, pp. 3799-3809. https://doi.org/10.1378/chest.128.6.3799
Ries, Andrew L. ; Make, Barry J. ; Lee, Shing M. ; Krasna, Mark J. ; Bartels, Matthew N. ; Crouch, Rebecca ; Fishman, Alfred P. / The effects of pulmonary rehabilitation in the National Emphysema Treatment Trial. In: Chest. 2005 ; Vol. 128, No. 6. pp. 3799-3809.
@article{82280ce9adf44e33afc0f7ff4d424f78,
title = "The effects of pulmonary rehabilitation in the National Emphysema Treatment Trial",
abstract = "Study objectives: Pulmonary rehabilitation is an established treatment in patients with chronic lung disease but is not widely utilized. Most trials have been conducted in single centers. The National Emphysema Treatment Trial (NETT) provided an opportunity to evaluate pulmonary rehabilitation in a large cohort of patients who were treated in centers throughout the United States. Design: Prospective observational study of cohort prior to randomization in a multicenter clinical trial. Setting: University-based clinical centers and community-based satellite pulmonary rehabilitation programs. Patients and intervention: A total of 1,218 patients with severe emphysema underwent pulmonary rehabilitation before and after randomization to lung volume reduction surgery (LVRS) or continued medical management. Rehabilitation was conducted at 17 NETT centers supplemented by 539 satellite centers. Measurements and results: Lung function, exercise tolerance, dyspnea, and quality of life were evaluated at regular intervals. Significant (p < 0.001) improvements were observed consistently in exercise (cycle ergometry, 3.1 W; 6-min walk test distance, 76 feet), dyspnea (University of California, San Diego Shortness of Breath Questionnaire score, -3.2; Borg breathlessness score: breathing cycle, -0.8; 6-min walk, -0.5) and quality of life (St. George Respiratory Questionnaire score, -3.5; Quality of Well-Being Scale score, +0.035; Medical Outcomes Study 36-item short form score: physical health summary, +1.3; mental health summary, + 2.0). Patients who had not undergone prior rehabilitation improved more than those who had. In multivariate models, only prior rehabilitation status predicted changes after rehabilitation. In 20{\%} of patients, exercise level changed sufficiently after rehabilitation to alter the NETT subgroup predictive of outcome. Overall, changes after rehabilitation did not predict differential mortality or improvement in exercise (primary outcomes) by treatment group. Conclusions: The NETT experience demonstrates the effectiveness of pulmonary rehabilitation in patients with severe emphysema who were treated in a national cross-section of programs. Pulmonary rehabilitation plays an important role in preparing and selecting patients for surgical interventions such as LVRS.",
keywords = "COPD, Pulmonary exercise, Pulmonary rehabilitation",
author = "Ries, {Andrew L.} and Make, {Barry J.} and Lee, {Shing M.} and Krasna, {Mark J.} and Bartels, {Matthew N.} and Rebecca Crouch and Fishman, {Alfred P.}",
year = "2005",
month = "12",
doi = "10.1378/chest.128.6.3799",
language = "English (US)",
volume = "128",
pages = "3799--3809",
journal = "Chest",
issn = "0012-3692",
publisher = "American College of Chest Physicians",
number = "6",

}

TY - JOUR

T1 - The effects of pulmonary rehabilitation in the National Emphysema Treatment Trial

AU - Ries, Andrew L.

AU - Make, Barry J.

AU - Lee, Shing M.

AU - Krasna, Mark J.

AU - Bartels, Matthew N.

AU - Crouch, Rebecca

AU - Fishman, Alfred P.

PY - 2005/12

Y1 - 2005/12

N2 - Study objectives: Pulmonary rehabilitation is an established treatment in patients with chronic lung disease but is not widely utilized. Most trials have been conducted in single centers. The National Emphysema Treatment Trial (NETT) provided an opportunity to evaluate pulmonary rehabilitation in a large cohort of patients who were treated in centers throughout the United States. Design: Prospective observational study of cohort prior to randomization in a multicenter clinical trial. Setting: University-based clinical centers and community-based satellite pulmonary rehabilitation programs. Patients and intervention: A total of 1,218 patients with severe emphysema underwent pulmonary rehabilitation before and after randomization to lung volume reduction surgery (LVRS) or continued medical management. Rehabilitation was conducted at 17 NETT centers supplemented by 539 satellite centers. Measurements and results: Lung function, exercise tolerance, dyspnea, and quality of life were evaluated at regular intervals. Significant (p < 0.001) improvements were observed consistently in exercise (cycle ergometry, 3.1 W; 6-min walk test distance, 76 feet), dyspnea (University of California, San Diego Shortness of Breath Questionnaire score, -3.2; Borg breathlessness score: breathing cycle, -0.8; 6-min walk, -0.5) and quality of life (St. George Respiratory Questionnaire score, -3.5; Quality of Well-Being Scale score, +0.035; Medical Outcomes Study 36-item short form score: physical health summary, +1.3; mental health summary, + 2.0). Patients who had not undergone prior rehabilitation improved more than those who had. In multivariate models, only prior rehabilitation status predicted changes after rehabilitation. In 20% of patients, exercise level changed sufficiently after rehabilitation to alter the NETT subgroup predictive of outcome. Overall, changes after rehabilitation did not predict differential mortality or improvement in exercise (primary outcomes) by treatment group. Conclusions: The NETT experience demonstrates the effectiveness of pulmonary rehabilitation in patients with severe emphysema who were treated in a national cross-section of programs. Pulmonary rehabilitation plays an important role in preparing and selecting patients for surgical interventions such as LVRS.

AB - Study objectives: Pulmonary rehabilitation is an established treatment in patients with chronic lung disease but is not widely utilized. Most trials have been conducted in single centers. The National Emphysema Treatment Trial (NETT) provided an opportunity to evaluate pulmonary rehabilitation in a large cohort of patients who were treated in centers throughout the United States. Design: Prospective observational study of cohort prior to randomization in a multicenter clinical trial. Setting: University-based clinical centers and community-based satellite pulmonary rehabilitation programs. Patients and intervention: A total of 1,218 patients with severe emphysema underwent pulmonary rehabilitation before and after randomization to lung volume reduction surgery (LVRS) or continued medical management. Rehabilitation was conducted at 17 NETT centers supplemented by 539 satellite centers. Measurements and results: Lung function, exercise tolerance, dyspnea, and quality of life were evaluated at regular intervals. Significant (p < 0.001) improvements were observed consistently in exercise (cycle ergometry, 3.1 W; 6-min walk test distance, 76 feet), dyspnea (University of California, San Diego Shortness of Breath Questionnaire score, -3.2; Borg breathlessness score: breathing cycle, -0.8; 6-min walk, -0.5) and quality of life (St. George Respiratory Questionnaire score, -3.5; Quality of Well-Being Scale score, +0.035; Medical Outcomes Study 36-item short form score: physical health summary, +1.3; mental health summary, + 2.0). Patients who had not undergone prior rehabilitation improved more than those who had. In multivariate models, only prior rehabilitation status predicted changes after rehabilitation. In 20% of patients, exercise level changed sufficiently after rehabilitation to alter the NETT subgroup predictive of outcome. Overall, changes after rehabilitation did not predict differential mortality or improvement in exercise (primary outcomes) by treatment group. Conclusions: The NETT experience demonstrates the effectiveness of pulmonary rehabilitation in patients with severe emphysema who were treated in a national cross-section of programs. Pulmonary rehabilitation plays an important role in preparing and selecting patients for surgical interventions such as LVRS.

KW - COPD

KW - Pulmonary exercise

KW - Pulmonary rehabilitation

UR - http://www.scopus.com/inward/record.url?scp=30344432064&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=30344432064&partnerID=8YFLogxK

U2 - 10.1378/chest.128.6.3799

DO - 10.1378/chest.128.6.3799

M3 - Article

VL - 128

SP - 3799

EP - 3809

JO - Chest

JF - Chest

SN - 0012-3692

IS - 6

ER -